Cargando…
Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure
BACKGROUND: Headache recurrence is a common feature of acute therapies, whether approved or still in development, and continues to be a significant problem for both the patient and the clinician. Further complicating this issue is lack of standardization in definitions of recurrence used in clinical...
Autores principales: | Tepper, Stewart J., Ailani, Jessica, Ray, Sutapa, Hirman, Joe, Shrewsbury, Stephen B., Aurora, Sheena K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682643/ https://www.ncbi.nlm.nih.gov/pubmed/36414952 http://dx.doi.org/10.1186/s10194-022-01519-4 |
Ejemplares similares
-
A link between gastrointestinal disorders and migraine: Insights into the gut–brain connection
por: Aurora, Sheena K., et al.
Publicado: (2021) -
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action
por: Cooper, Wade, et al.
Publicado: (2022) -
Patient‐identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient‐centered outcome
por: Lipton, Richard B., et al.
Publicado: (2021) -
Nasal Delivery of Acute Medications for Migraine: The Upper Versus Lower Nasal Space
por: Martin, Vincent, et al.
Publicado: (2021) -
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
por: Detke, Holland C., et al.
Publicado: (2019)